UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by D L Carlson Investment Group Inc.

D L Carlson Investment Group Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,689 shares of the healthcare conglomerate's stock after selling 2,527 shares during the period. D L Carlson Investment Group Inc.'s holdings in UnitedHealth Group were worth $4,395,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $32,000. Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at $40,000. Finally, Legacy Investment Solutions LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $57,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UNH stock traded up $21.97 during trading on Thursday, reaching $545.17. 2,741,616 shares of the company were exchanged, compared to its average volume of 4,230,006. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market cap of $498.67 billion, a P/E ratio of 35.17, a PEG ratio of 1.37 and a beta of 0.62. The stock's 50 day moving average price is $509.15 and its 200 day moving average price is $542.83.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the business posted $5.83 EPS. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.54%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is currently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. KeyCorp restated an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research note on Thursday, December 5th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.